ES2061655T3 - Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos. - Google Patents

Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.

Info

Publication number
ES2061655T3
ES2061655T3 ES88306022T ES88306022T ES2061655T3 ES 2061655 T3 ES2061655 T3 ES 2061655T3 ES 88306022 T ES88306022 T ES 88306022T ES 88306022 T ES88306022 T ES 88306022T ES 2061655 T3 ES2061655 T3 ES 2061655T3
Authority
ES
Spain
Prior art keywords
human
cultivating
procedure
hybridoma producing
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88306022T
Other languages
English (en)
Inventor
Hideaki Hagiwara
Masafumi Naito
Hideo Yuasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2061655T3 publication Critical patent/ES2061655T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN MEDIO EXENTO DE SUERO PARA CULTIVAR UN HIBRIDOMA HUMANO/HUMANO PRODUCTOR DE UN ANTICUERPO MONOCLONAL HUMANO, COMPRENDIENDO DICHO MEDIO UN MEDIO COMPLETO EXENTO DE SUERO Y, AL MENOS, 10EXP-12 M, PERO NO MAS DE 10EXP-6 M, DE ACIDO RETINOICO O UNA SAL SUYA.
ES88306022T 1987-08-21 1988-07-01 Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos. Expired - Lifetime ES2061655T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62206569A JPH0634713B2 (ja) 1987-08-21 1987-08-21 ヒト／ヒト・ハイブリドーマの培養方法

Publications (1)

Publication Number Publication Date
ES2061655T3 true ES2061655T3 (es) 1994-12-16

Family

ID=16525567

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88306022T Expired - Lifetime ES2061655T3 (es) 1987-08-21 1988-07-01 Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.

Country Status (10)

Country Link
US (1) US5155036A (es)
EP (1) EP0304150B1 (es)
JP (1) JPH0634713B2 (es)
KR (1) KR940003651B1 (es)
AU (1) AU615918B2 (es)
CA (1) CA1299509C (es)
DE (1) DE3887030T2 (es)
ES (1) ES2061655T3 (es)
IL (1) IL86830A0 (es)
RU (1) RU2018532C1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009220A1 (en) * 1991-11-06 1993-05-13 Correa Paulo N Cell culture medium
US6037174A (en) * 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5846529A (en) * 1993-08-23 1998-12-08 Nexell Therapeutics, Inc. Infusion of neutrophil precursors for treatment of neutropenia
US20030077757A1 (en) * 2000-01-11 2003-04-24 Andrews William H. Method of treating aging-related disorders
EP1549678A4 (en) * 2002-09-30 2006-01-18 Pfizer Prod Inc HYBRIDOMAS THAT PRODUCE HIGH CONCENTRATIONS OF ANTIBODIES TO THE HUMAN SEQUENCE
CN107099508A (zh) * 2017-06-23 2017-08-29 曲宝赤 一种无血清杂交瘤细胞培养基

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205126A (en) * 1978-01-01 1980-05-27 Cartaya Oscar A Serum-free cell culture media

Also Published As

Publication number Publication date
IL86830A0 (en) 1988-11-30
EP0304150A2 (en) 1989-02-22
DE3887030T2 (de) 1994-04-28
US5155036A (en) 1992-10-13
KR940003651B1 (ko) 1994-04-25
EP0304150A3 (en) 1989-08-30
KR890003944A (ko) 1989-04-19
DE3887030D1 (de) 1994-02-24
RU2018532C1 (ru) 1994-08-30
JPS6451079A (en) 1989-02-27
JPH0634713B2 (ja) 1994-05-11
EP0304150B1 (en) 1994-01-12
CA1299509C (en) 1992-04-28
AU615918B2 (en) 1991-10-17
AU1842188A (en) 1989-02-23

Similar Documents

Publication Publication Date Title
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ATE208820T1 (de) Humanisierte antikoerper
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EP0675904A4 (en) HUMANE NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE VIRUS FROM HUMAN THAT MAKES THE IMMUNE.
MX9205169A (es) Proceso para la produccion de gel suave.
MX9201563A (es) Dexilosilbenanomicina b y procedimiento para prepararla.
DE3684211D1 (es)
NO870476L (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
ES2061655T3 (es) Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.
DK355483D0 (da) Monoklonale antistoffer til krydsafstemning af humant vaev
FI894650A (fi) Antigen, som associerar till en human tumoer.
DK0585570T3 (da) Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
ATE317021T1 (de) Antisense modulierung von lfa-3
ES2090331T3 (es) Ctaa 28a32, antigeno reconocido por mca 28a32.
FR2668027B1 (fr) Poutre-cheneau pour serres.
PT70524A (fr) Procede de preparation d'ethers insatures
FI974018A (fi) Ihmisen 2 integriini -alayksikkö
DE3881101D1 (de) Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
IT8125157A0 (it) Procedimento per la preparazione di 2-amminoetanoli.
NO900092D0 (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.
IT7919222A0 (it) Procedimento per produrre anticorpi umani.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 304150

Country of ref document: ES